<DOC>
	<DOC>NCT02523690</DOC>
	<brief_summary>ICU acquired muscle weakness is a significant problem in patients recovering from critical illness. This trial will evaluate the safety and efficacy of a drug in improving muscle weakness in critically ill patients.</brief_summary>
	<brief_title>Evaluating Muscle Weakness Improvement With Lorcaserin in ICU</brief_title>
	<detailed_description />
	<mesh_term>Muscle Weakness</mesh_term>
	<mesh_term>Paresis</mesh_term>
	<criteria>1. Age ≥18 years old 2. Sepsis [ ≥2 Systemic Inflammatory Response Syndrome (SIRS) Criteria AND known or suspected infection] 3. Muscle weakness [Medical Research Council sum score &lt;48/60 or handgrip strength &lt;11 kg in men and &lt;7 kg in women] 4. Obey Commands [Score for DeJonghe Awakening Score of ≥3/5] 1. Severe renal insufficiency [Creatinine Clearance &lt;30 mL/min or receiving dialysis] 2. Acute infectious or autoimmune hepatitis, acute liver failure or a history of cirrhosis without liver transplant 3. History of psychosis 4. Bradycardia, or 2nd or 3rd degree AV block without pacemaker 5. History of valvular heart disease without valve replacement 6. History of priapism 7. Preexisting cognitive impairment 8. Receiving drugs with serotonergic effects and/or CYP2D6 substrates which cannot be substituted stopped or titrated. 9. Receiving Sulfonylurea medication at the time of the study 10. Prior neuromuscular or central nervous system disease, including preexisting neuropathy 11. Inability to perform study's muscle strength assessments based on patient's baseline status prior to hospital admission 12. Unable to receive, or unlikely to absorb study drug (e.g. bowel obstruction, ischemia, or infarction; short gut syndrome) 13. Body mass index &gt;40 14. Patient not expected to survive &gt;4 days 15. Pregnancy or lactation 16. Allergy to lorcaserin or lorcaserin taken in the prior 7 days 17. Enrolled in another interventional drug or physical rehabilitation trial 18. Physician declines for patient to be enrolled 19. Patient or proxy declines consent 20. Unable to reach proxy for consent 21. NonEnglish speaking</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>